{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:28:01Z","timestamp":1794439681122,"version":"4.9.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016469","name":"Takeda Pharmaceuticals International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals USA Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1053\/j.gastro.2021.03.019","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T18:06:21Z","timestamp":1616004381000},"page":"81-93.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Gluten Degradation, Pharmacokinetics, Safety, and Tolerability of TAK-062, an Engineered Enzyme to Treat Celiac Disease"],"prefix":"10.1053","volume":"161","author":[{"given":"Ingrid Swanson","family":"Pultz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne M.","family":"Vitanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clancey","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse","family":"Saaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Winkle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Leffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2021.03.019_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1126\/scitranslmed.3001012","article-title":"Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease","volume":"2","author":"Tye-Din","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1053\/j.gastro.2021.03.019_bib2","first-page":"17","article-title":"Genetic susceptibility and celiac disease: what role do HLA haplotypes play?","volume":"89","author":"Sciurti","year":"2018","journal-title":"Acta Biomed"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2021.03.019_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/jgh.13703","article-title":"What is gluten?","volume":"32","author":"Biesiekierski","year":"2017","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.03.019_bib4","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2015.01.044","article-title":"Celiac disease","volume":"135","author":"Green","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1053\/j.gastro.2021.03.019_bib5","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ajg.2013.79","article-title":"ACG clinical guidelines: diagnosis and management of celiac disease","volume":"108","author":"Rubio-Tapia","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.03.019_bib6","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cgh.2017.06.037","article-title":"Global prevalence of celiac disease: systematic review and meta-analysis","volume":"16","author":"Singh","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.03.019_bib7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jval.2016.12.016","article-title":"A\u00a0novel patient-derived conceptual model of the impact of celiac disease in adults: implications for patient-reported outcome and health-related quality-of-life instrument development","volume":"20","author":"Leffler","year":"2017","journal-title":"Value Health"},{"key":"10.1053\/j.gastro.2021.03.019_bib8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/1756283X13492580","article-title":"Interest in medical therapy for celiac disease","volume":"6","author":"Tennyson","year":"2013","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1053\/j.gastro.2021.03.019_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clim.2009.11.001","article-title":"The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in\u00a0vivo","volume":"134","author":"Tye-Din","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1053\/j.gastro.2021.03.019_bib10","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1365-2036.2008.03669.x","article-title":"Systematic review: tolerable amount of gluten for people with coeliac disease","volume":"27","author":"Akobeng","year":"2008","journal-title":"Aliment Pharmacol Therap"},{"key":"10.1053\/j.gastro.2021.03.019_bib11","first-page":"26","article-title":"Even small amounts of gluten cause relapse in children with celiac disease","volume":"34","author":"Laurin","year":"2002","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2021.03.019_bib12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ajcn\/85.1.160","article-title":"A\u00a0prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease","volume":"85","author":"Catassi","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.gastro.2021.03.019_bib13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1053\/j.gastro.2007.05.028","article-title":"Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue","volume":"133","author":"Gass","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.03.019_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128065","article-title":"Ineffective degradation of immunogenic gluten epitopes by currently available digestive enzyme supplements","volume":"10","author":"Janssen","year":"2015","journal-title":"PloS One"},{"key":"10.1053\/j.gastro.2021.03.019_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/gut.2006.111609","article-title":"Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease","volume":"57","author":"Mitea","year":"2008","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.03.019_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/apt.13266","article-title":"Randomised clinical study: Aspergillus niger-derived enzyme digests gluten in the stomach of healthy volunteers","volume":"42","author":"Salden","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2021.03.019_bib17","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s10620-011-1906-5","article-title":"Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials","volume":"57","author":"Siegel","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2021.03.019_bib18","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/j.gastro.2014.02.031","article-title":"Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease","volume":"146","author":"L\u00e4hdeaho","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.03.019_bib19","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1053\/j.gastro.2016.11.004","article-title":"No difference between latiglutenase and placebo in reducing villous atrophy or improving symptoms in patients with symptomatic celiac disease","volume":"152","author":"Murray","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.03.019_bib20","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1007\/s10620-017-4687-7","article-title":"Latiglutenase improves symptoms in seropositive celiac disease patients while on a gluten-free diet","volume":"62","author":"Syage","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2021.03.019_bib21","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.3748\/wjg.v19.i35.5837","article-title":"Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study","volume":"19","author":"Tack","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.03.019_bib22","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1021\/jacs.5b08325","article-title":"Engineering of Kuma030: a gliadin peptidase that rapidly degrades immunogenic gliadin peptides in gastric conditions","volume":"137","author":"Wolf","year":"2015","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1053\/j.gastro.2021.03.019_bib23","doi-asserted-by":"crossref","first-page":"20513","DOI":"10.1021\/ja3094795","article-title":"Computational design of an \u03b1-gliadin peptidase","volume":"134","author":"Gordon","year":"2012","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1053\/j.gastro.2021.03.019_bib24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00251-012-0599-z","article-title":"Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules","volume":"64","author":"Sollid","year":"2012","journal-title":"Immunogenetics"},{"key":"10.1053\/j.gastro.2021.03.019_bib25","doi-asserted-by":"crossref","first-page":"e2294","DOI":"10.1371\/journal.pone.0002294","article-title":"Toward the assessment of food toxicity for celiac patients: characterization of monoclonal antibodies to a main immunogenic gluten peptide","volume":"3","author":"Moron","year":"2008","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2021.03.019_bib26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/ajcn\/87.2.405","article-title":"Sensitive detection of cereal fractions that are toxic to celiac disease patients by using monoclonal antibodies to a main immunogenic wheat peptide","volume":"87","author":"Mor\u00f3n","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.gastro.2021.03.019_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.14227\/DT190312P15","article-title":"The design, operation, and application of a dynamic gastric model","volume":"19","author":"Wickham","year":"2012","journal-title":"Dissol Technol"},{"key":"10.1053\/j.gastro.2021.03.019_bib28","series-title":"The impact of food bioactives on health","first-page":"47","article-title":"Dynamic gastric model (DGM)","author":"Thuenemann","year":"2015"},{"key":"10.1053\/j.gastro.2021.03.019_bib29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.appet.2013.04.016","article-title":"Intentional and inadvertent non-adherence in adult coeliac disease. A cross-sectional survey","volume":"68","author":"Hall","year":"2013","journal-title":"Appetite"},{"key":"10.1053\/j.gastro.2021.03.019_bib30","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1053\/j.gastro.2005.06.016","article-title":"Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease","volume":"129","author":"Matysiak\u2013Budnik","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.03.019_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5740\/jaoacint.12-271","article-title":"Validation study of the Veratox R5 rapid ELISA for detection of gliadin","volume":"96","author":"Lupo","year":"2013","journal-title":"JAOAC Int"},{"key":"10.1053\/j.gastro.2021.03.019_bib32","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3390\/foods4040654","article-title":"Comparison of R5 and G12 antibody-based ELISA used for the determination of the gluten content in official food samples","volume":"4","author":"Hochegger","year":"2015","journal-title":"Foods"},{"key":"10.1053\/j.gastro.2021.03.019_bib33","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/ajcn\/nqaa188","article-title":"Negative predictive value of the repeated absence of gluten immunogenic peptides in the urine of treated celiac patients in predicting mucosal healing: new proposals for follow-up in celiac disease","volume":"112","author":"Ruiz-Carnicer","year":"2020","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.gastro.2021.03.019_bib35","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s10620-011-1906-5","article-title":"Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials","volume":"57","author":"Siegel","year":"2012","journal-title":"Dig Dis Sci"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508521005278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508521005278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T15:33:44Z","timestamp":1758036824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508521005278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0016508521005278"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2021.03.019","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gluten Degradation, Pharmacokinetics, Safety, and Tolerability of TAK-062, an Engineered Enzyme to Treat Celiac Disease","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2021.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the AGA Institute. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}